Micro Imaging Tech (MMTC) 0.3001 $MMTC Northern Michigan

Micro Imaging Tech (MMTC) 0.3001 $MMTC

Northern Michigan University Research With MIT 1000 Garners Award
Marketwired - Fri Apr 29, 9:45AM CDT
Micro Imaging Technology, Inc. ("MIT" (OTCQB: MMTC) -- The 2016 Celebration of Student Research competition at Northern Michigan University ("NMU" resulted in a first place Group Poster Award for research consequential to the collaborative effort between MIT and the NMU Department of Biology (see: http://www.nmu.edu/studentcelebra tion/2016-celebration-and-technology-photos#overlay-context=).Dr. Josh S. Sharp, assistant professor at NMU, his department, and his students have been spearheading a research program to develop clinical applications and methods for rapid identification of pathogens, particularly Staphylococcus aureus (S. aureus) and Methicillin Resistant S. aureus (MRSA,) using the company's MIT 1000 pathogen detection and identification system. Dr. Sharp and his students, along with Dr. Amit Morey of Auburn University, and Dr. David Haavig of MIT, developed a new sample preparation method that eliminates long culture plate growth periods and significantly reduces the pathogen detection and confirmation time to 6 hours or less, after the sample was taken from the patient, food sample or other initial target.

Micro Imaging Technology Adds STAPH AUREUS to Its Catalog of Identifiers
Marketwired - Thu Jan 14, 7:02AM CST
Micro Imaging Technology, Inc. ("MIT" (OTCQB: MMTC) announced that its MIT 1000 System can now identify Staphylococcus aureus ("S. aureus" , a bacterial pathogen which can cause skin infections and commonly leads to abscess formation. S. aureus sometimes can also lead to pneumonia, endocarditis, and osteomyelitis. It is also a common food contaminant. "This is a significant step forward for the MIT 1000 technology," said Dr. David Haavig, Micro Imaging Technology's Chief Scientist. "The completion of this S. aureus Identifier, which gives the MIT 1000 System the ability to identify S. aureus, continues to demonstrate the sensitivity of this non-biological bacterial identification technology and adds to MIT's growing catalog of Identifiers. Adding S. aureus to our catalog of Identifier's, gets MIT one step closer to creating an Identifier for the superbug, Methicillin Resistant S. aureus also known as MRSA."

Micro Imaging Technology Adds Enterococcus Faecalis to Its Catalog of Identifiers
Marketwired - Wed Sep 09, 6:01AM CDT
Micro Imaging Technology, Inc. (OTCQB: MMTC) announced that its MIT 1000 System can now identify Enterococcus faecalis, a bacterial species found in human feces and in the intestines of many warm-blooded animals; occasionally found in urinary infections and in blood and heart lesions in cases of subacute endocarditis. E. faecalis can cause life-threatening infections in humans, especially in the hospital environment, where the naturally high levels of antibiotic resistance found in E. faecalis contribute to its pathogenicity. E. faecalis has been frequently found in root canal-treated teeth which are about nine times more likely to harbor the bacteria than cases of primary infections.

MIT reports breakthrough MIT 1000, stand-alone, rapid, optically-based, software driven system in pathogen testing
M2 - Mon Jul 27, 4:08AM CDT
Micro Imaging Technology (OTCQB:MMTC) stated on Friday that it has developed a testing protocol that allows for detection of pathogen species from liquid cultures in collaboration with Northern Michigan University (NMU).

MIT Announces Breakthrough in Pathogen Testing
Marketwired - Fri Jul 24, 7:00AM CDT
Micro Imaging Technology, Inc. (OTCQB: MMTC) announced that, through its collaboration with Northern Michigan University (NMU), it has developed a testing protocol that allows for detection of pathogen species from liquid cultures. Dr. Josh S. Sharp, Ph.D., assistant professor at the NMU Department of Biology in Marquette, Michigan, has been spearheading the collaboration between MIT and NMU since October of 2013. He is researching clinical applications of the MIT 1000 System, particularly the pathogens Staphylococcus aureus (S. aureus) and Methicillin Resistant S. aureus (MRSA). "Many of the current agar plate based identification methods require 16-24 hours of growth before identifications can be made," said Dr. Sharp. "Our work with MIT and its rapid laser-based identification system, the MIT 1000, has effectively eliminated the need for that time-consuming step and reduced the time required for pathogen sample preparation and identification to 4-6 hours given a sufficient starting inoculum. This new protocol allows for detection of Staphylococcus species from liquid cultures and has provided important groundwork to facilitate rapid enrichment of target bacteria for identification using the MIT 1000."

MIT to Present at the 2015 IAFP Conference
Marketwired - Mon Jul 13, 6:00AM CDT
Micro Imaging Technology, Inc. (OTCQB: MMTC) announced that it has been invited by the International Association for Food Protection to give a presentation at its 2015 annual meeting later this month in Portland, Oregon. Dr. David Haavig, MIT's Chief Scientific Officer, will be a speaker at the symposium covering "Novel Frontiers in Microbiology -- Recent Advances in Non-DNA based Rapid Microbial Detection and Identification Methods." He will share the unique scientific and innovative technology of the MIT 1000, a bacterial cell based identification system that can identify pathogenic bacteria in three minutes (average) at significant cost savings per test. As well, he will touch upon the latest advances in testing procedures that the MIT 1000 has spurred.

Perfect Score for MIT 1000 on Staphylococcus Single Blind Identification Study
Marketwired - Thu May 21, 5:00AM CDT
Micro Imaging Technology, Inc. (OTCQB: MMTC) announced the result of a blind study conducted with its MIT 1000 System as part of a collaboration with Northern Michigan University (NMU) to identify and differentiate Staphylococcus aureus (S. aureus). The study was conducted by the NMU lab of Josh Sharp, Ph.D., Assistant Professor of Biology, in cooperation with the Microbiology lab at UP Health Systems in Marquette, Michigan to investigate whether the MIT 1000 System was able to detect S. aureus strains isolated from humans. In the single blind study, UP Health Systems provided 90 different previously tested, but unidentified cultures of bacteria to the Sharp lab to determine whether clinical isolates of S. aureus could be identified with the MIT 1000. Clinical isolates might have more variability in characteristics such as size, shape and pigment production compared to laboratory strains and, therefore, more challenging to identify. Out of those 90 samples, the MIT 1000 identified 30 as Staphylococcus species -- a 100% match to the hospital's independent test findings. Not only did the MIT 1000 accurately identify the 30 cultures of various Staphylococcus species, but the remaining 60 non-Staphylococcus cultures tested in the study were correctly ruled out as Staph species (no false positives).